SPC201

Baricítíníb og lyfjafræðilega viðunandi sölt þar af

  • Status:
    Veitt
  • Application date:
    8.8.2017
  • Application published:
    15.9.2017
  • Grant published:
    15.5.2019
  • Max expiry date:
    14.2.2032
  • Medicine name:
    Olumiant
  • Medicine for children:
    No

Timeline

Today
8.8.2017Application
15.9.2017Publication
15.5.2019Registration
14.2.2032Expires

Marketing license

  • IS authorization number:
    EU/1/16/1170/009-016; EU/1/16/1170/001-008
  • Date:
    21.2.2017
  • Foreign authorization number:
    EU/1/16/1170
  • Date:
    13.2.2017

Owner

  • Name:
    Incyte Holdings Corporation
  • Address:
    1801 Augustine Cut-Off, Wilmington US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents